Abe Ikubo & Katayama

Intellectual property

Work highlights

Represented Kowa in an appeal of an infringement suit, accusing Kowa in its manufacture and sale of the product for treatment of Meniere's disease. This case is important because it involves a new issue under the patent law on the scope of the dosage claim in case that the accused drug is in off label use.

Represented Eli Lilly against three generic companies in a patent invalidation action concerning a patent covering Lilly’s most sold cancer drug Alimta.

Represented the plaintiff, Kowa, and obtained a permanent injunction decision by the Tokyo district court prohibiting a defendant, Towa Pharmaceutical, a generic drugmaker, from manufacturing and selling its generic drug for the plaintiff’s pitavastatin drug Livalo.

Client feedback

“The lawyers and patent attorneys at the firm have excellent abilities and are experienced in litigation cases and obtaining patent rights.” – Intellectual property
“Katayama sensei has excellent knowledge and experience of patent litigations and obtaining patent rights. He usually provide us with excellent advice.” - Eiji Katayama